{"id":"https://openalex.org/W2560817153","doi":"https://doi.org/10.1182/blood.v104.11.3404.3404","title":"Rituximab-Mediated Molecular Cell Signaling Via CD20 in B-NHL Cell Lines: Autonomy from Cross-Linking with Tumor FcRs.","display_name":"Rituximab-Mediated Molecular Cell Signaling Via CD20 in B-NHL Cell Lines: Autonomy from Cross-Linking with Tumor FcRs.","publication_year":2004,"publication_date":"2004-11-16","ids":{"openalex":"https://openalex.org/W2560817153","doi":"https://doi.org/10.1182/blood.v104.11.3404.3404","mag":"2560817153"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v104.11.3404.3404","doi":"https://doi.org/10.1182/blood.v104.11.3404.3404","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.3404.3404","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067305483","display_name":"Mario I. Vega","orcid":"https://orcid.org/0000-0002-3932-2483","observed_orcids":["https://orcid.org/0000-0002-3932-2483"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mario I. Vega","raw_affiliation_strings":["Inmunologia e Infectologia, Unidad de Investigacion Medica, Calzada Vallejo, La Raza, Mexico","Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inmunologia e Infectologia, Unidad de Investigacion Medica, Calzada Vallejo, La Raza, Mexico","institution_ids":[]},{"raw_affiliation_string":"Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082889084","display_name":"Sara Huerta\u2010Y\u00e9pez","orcid":"https://orcid.org/0000-0001-5633-6249","observed_orcids":["https://orcid.org/0000-0001-5633-6249"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sara Huerta-Yepez","raw_affiliation_strings":["Inmunologia e Infectologia, Unidad de Investigacion Medica, Calzada Vallejo, La Raza, Mexico","Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inmunologia e Infectologia, Unidad de Investigacion Medica, Calzada Vallejo, La Raza, Mexico","institution_ids":[]},{"raw_affiliation_string":"Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037794112","display_name":"Paul C. Chinn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paul Chinn","raw_affiliation_strings":["Biogen-IDEC Pharaceuticals, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen-IDEC Pharaceuticals, San Diego, CA, USA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037533432","display_name":"Hari Hariharan","orcid":"https://orcid.org/0000-0002-7032-6968","observed_orcids":["https://orcid.org/0000-0002-7032-6968"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hari Hariharan","raw_affiliation_strings":["Biogen-IDEC Pharaceuticals, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen-IDEC Pharaceuticals, San Diego, CA, USA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074473587","display_name":"Nabil Hanna","orcid":"https://orcid.org/0000-0002-3288-5486","observed_orcids":["https://orcid.org/0000-0002-3288-5486"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nabil Hanna","raw_affiliation_strings":["Biogen-IDEC Pharaceuticals, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen-IDEC Pharaceuticals, San Diego, CA, USA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055490703","display_name":"Benjamin Bonavida","orcid":"https://orcid.org/0000-0001-5594-2060","observed_orcids":["https://orcid.org/0000-0001-5594-2060"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Bonavida","raw_affiliation_strings":["Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5037533432","https://openalex.org/A5037794112","https://openalex.org/A5067305483","https://openalex.org/A5074473587","https://openalex.org/A5082889084"],"corresponding_institution_ids":["https://openalex.org/I1297540436","https://openalex.org/I161318765"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2824,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.68159729,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"104","issue":"11","first_page":"3404","last_page":"3404"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5889000296592712,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5889000296592712,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.39399999380111694,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.9190000295639038},{"id":"https://openalex.org/keywords/b-cell-non-hodgkin-lymphoma","display_name":"B-cell non-Hodgkin lymphoma","score":0.9269999861717224},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.49900001287460327},{"id":"https://openalex.org/keywords/cell-proliferation-inhibition","display_name":"cell proliferation inhibition","score":0.6800000071525574},{"id":"https://openalex.org/keywords/p38-mapk","display_name":"p38 MAPK","score":0.9670000076293945},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.972000002861023},{"id":"https://openalex.org/keywords/stat3","display_name":"STAT3","score":0.843999981880188}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.9320640563964844},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.7558072209358215},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.6890044808387756},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.563170313835144},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.55963134765625},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.445893794298172},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4328739643096924},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.428036093711853},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.417168527841568},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3933602273464203},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34378373622894287}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v104.11.3404.3404","doi":"https://doi.org/10.1182/blood.v104.11.3404.3404","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.3404.3404","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7900000214576721,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2119197910","https://openalex.org/W2017009058","https://openalex.org/W2578360777","https://openalex.org/W2018518082","https://openalex.org/W2029635926","https://openalex.org/W3086243114","https://openalex.org/W2172473781","https://openalex.org/W2026040447","https://openalex.org/W2123602110","https://openalex.org/W2162305597"],"abstract_inverted_index":{"Abstract":[0],"Rituximab":[1],"(chimeric":[2],"anti-CD20":[3],"mAb)":[4],"is":[5,29,143],"currently":[6],"being":[7],"used":[8,208],"in":[9,31,44,72,112,141,159,196,228,268,316,346,374,376],"the":[10,23,61,73,118,122,138,149,161,189,204,223,245,259,282,286,293,297,302,317,347,353,358,377],"therapy":[11],"of":[12,25,75,125,188,203,319,339,349,352,379,385],"Non-Hodgkin\u2019s":[13],"B-cell":[14],"Lymphoma":[15],"(NHL).":[16],"It":[17],"has":[18],"also":[19],"been":[20,39],"reported":[21,56],"that":[22,57,222,334,365],"combination":[24],"rituximab":[26,58,157,177,183,290,370],"and":[27,46,50,64,179,199,210,234,240,250,270,291,308,310,327,337,367,382],"chemotherapy":[28],"effective":[30],"patients":[32],"with":[33,114,148,173,201,256,275],"NHL.":[34],"Several":[35],"proposed":[36],"mechanisms":[37],"have":[38,55,104,153],"suggested":[40],"for":[41,145],"rituximab-mediated":[42,335],"effects":[43],"vivo":[45,375],"include":[47],"ADCC,":[48],"CDC":[49],"apoptosis.":[51,329],"In":[52,280],"addition,":[53,281],"we":[54,152,220],"can":[59,343,371],"trigger":[60],"tumor":[62,76,119],"cells":[63,77,120,168,246,287],"modifies":[65],"several":[66,197],"intracellular":[67,340],"survival":[68],"signaling":[69,102,336,341],"pathways":[70,342],"resulting":[71],"sensitization":[74,318],"to":[78,131,231,243,253,289,323,357],"various":[79],"chemotherapeutic":[80,325],"drugs":[81,326],"(Alas":[82],"et":[83,90,97],"al.,":[84,91,98],"Clin.":[85],"Cancer":[86,93],"Res.8:836,":[87],"2001;":[88],"Jazirehi":[89],"Mol.":[92],"Therapy2:1183,":[94],"2003;":[95],"Vega":[96],"Oncogene23:3530,":[99],"2004).":[100],"Rituximab-mediated":[101],"might":[103],"resulted":[105,315],"from":[106],"directly":[107],"triggering":[108,115],"CD20":[109],"alone":[110],"or":[111],"conjunction":[113],"FcRs":[116],"on":[117],"via":[121],"Fc":[123,142,150,354,360],"fragment":[124,355],"rituximab.":[126,206,257],"This":[127],"study":[128],"was":[129,164],"designed":[130],"distinguish":[132],"between":[133],"these":[134,331],"two":[135,190],"possibilities.":[136],"Since":[137],"CH2":[139,162],"domain":[140,163,192],"responsible":[144],"its":[146],"interaction":[147],"receptor,":[151],"genetically":[154],"engineered":[155],"a":[156,180,276],"mAb":[158],"which":[160],"deleted.":[165],"The":[166,186],"CHO":[167],"secreted":[169],"one":[170],"monomeric":[171],"form":[172,182],"properly":[174],"formed":[175],"disulfides":[176],"(CH2\u2212)":[178,184],"dimeric":[181],"Dimer.":[185],"functions":[187,239],"CH2-deleted":[191,224,260,283],"antibodies":[193,225,261,284],"were":[194,247,251],"examined":[195],"systems":[198],"compared":[200],"those":[202,254],"native":[205],"We":[207],"Ramos":[209],"2F7":[211],"B-NHL":[212,320],"cell":[213,263,266,321,359],"lines":[214,322],"as":[215],"model":[216],"systems.":[217],"As":[218],"expected,":[219],"demonstrate":[221,333],"are":[226,384],"defective":[227],"their":[229,237,241],"ability":[230,242],"mediate":[232],"ADCC":[233],"CDC.":[235],"However,":[236],"biological":[238],"signal":[244],"not":[248],"altered":[249],"similar":[252,288],"observed":[255],"Hence,":[258],"inhibited":[262,292],"proliferation,":[264],"induced":[265,271],"aggregation":[267],"culture,":[269],"apoptosis":[272],"when":[273],"cross-linked":[274,356],"secondary":[277],"anti-human":[278],"IgG.":[279],"triggered":[285],"Src":[294],"kinase":[295],"pLyn,":[296],"downstream":[298],"p38":[299],"MAP":[300],"kinase,":[301],"transcription":[303],"factors":[304],"NF-\u03baB,":[305],"YY1,":[306],"SP1,":[307],"STAT3,":[309],"Bcl-2/Bcl-xL":[311],"expression.":[312],"These":[313,362],"modifications":[314],"both":[324],"Fas-induced":[328],"Altogether,":[330],"findings":[332],"modification":[338],"take":[344,372],"place":[345,373],"absence":[348,378],"any":[350],"contribution":[351],"receptors.":[361],"studies":[363],"suggest":[364],"chemo":[366],"immuno-sensitization":[368],"by":[369],"Fc-FcR":[380],"contributions":[381],"thus":[383],"potential":[386],"clinical":[387],"relevance.":[388]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-12-16T00:00:00"}